Key Market Segments
By Product Type
-
Instruments
-
Reagents & Consumables
By Technique
-
Immunodiagnostics
-
Clinical Chemistry
-
Molecular Diagnostics
-
Hematology
-
Others
By Sample Type
-
Blood
-
Urine
-
Saliva
-
Tissue
-
Others
By Application
-
Infectious Diseases
-
Cardiology
-
Oncology
-
Gastroenterology
-
Allergy
-
Autoimmunity
-
Prenatal Screening
-
Others
By End-User
-
Hospitals
-
Clinical Laboratories
-
Others
Request for Segment Customization as per your Business Requirement: Segment Customization Request
Regional Coverage:
North America
-
US
-
Canada
-
Mexico
Europe
-
Germany
-
France
-
UK
-
Italy
-
Spain
-
Poland
-
Turkey
-
Rest of Europe
Asia Pacific
-
China
-
India
-
Japan
-
South Korea
-
Singapore
-
Australia
-
Rest of Asia Pacific
Middle East & Africa
-
UAE
-
Saudi Arabia
-
Qatar
-
South Africa
-
Rest of Middle East & Africa
Latin America
-
Brazil
-
Argentina
-
Rest of Latin America
Request for Country Level Research Report: Country Level Customization Request
Available Customization
With the given market data, SNS Insider offers customization as per the company’s specific needs. The following customization options are available for the report:
-
Detailed Volume Analysis
-
Criss-Cross segment analysis (e.g., Product X Application)
-
Competitive Product Benchmarking
-
Geographic Analysis
-
Additional countries in any of the regions
-
Customized Data Representation
-
Detailed analysis and profiling of additional market players
Frequently Asked Questions
Ans: North America dominated the Lab-Based IVD market.
Ans: Although the lab-based IVD market is growing strongly, it is constrained by a complex regulatory environment and the high associated costs for developing, validating, and deploying new tests.
Ans: Rising demand for early and accurate diagnosis, owing to the surge in non-communicable diseases boosting the lab-based IVD market growth declining share for hospital-based diagnostics.
Ans: The market is expected to reach USD 67.03 billion by 2032, increasing from USD 42.54 billion in 2024.
Ans: The Lab-Based IVD market is anticipated to grow at a CAGR of 5.87% from 2025 to 2032.